Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4091-4097

  López Boado, Yolanda S ^a   Puente, Xose S ^a   Alvarez, Sonsoles ^a   Tolivia, Jorge ^a   Binderup, Lise ^b   López Otín, Carlos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b Leo Pharmaceutical Products ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN D; CALCITRIOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PREVENTION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOLIPOPROTEINS; APOLIPOPROTEINS D; BREAST NEOPLASMS; CALCITRIOL; CARCINOMA; CYCLOHEXIMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; RNA, NEOPLASM; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 1842327415     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. McConathy, W. J., and Alaupovic, P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett., 37: 178-182, 1973.
2. Blanco-Vaca, F., Via, D. P., Yang, C., Massey, J. B., and Pownall, H. J. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J. Lipid Res., 32: 1785-1796, 1992.
3. Drayna, D., Fielding, C., McLean, J., Baer, B., Castro, G., Chen, E., Comstock, L., Henzel, W., Korh, W., Rhee, L., Wion, K., and Lawn, R. Cloning and expression of human apolipoprotein D cDNA. J. Biol. Chem., 261: 16535-16539, 1986.
4. Francone, O. L., Gurakar, A., and Fielding, C. Distribution and functions of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J. Biol. Chem., 264: 7066-7072, 1989.
5. Peitsch, M. C., and Boguski, M. S. Is apolipoprotein D a mammalian bilin-binding protein? New Biol., 2: 197-206, 1990.
6. Dilley, W. G., Haagensen, D. E., Cox, C. E., and Wells, S. A. Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid. Breast Cancer Res. Treat., 16: 253-260, 1990.
7. Balbín, M., Freije, J. M. P., Fueyo, A., Sánchez, L. M., and López-Otín, C. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem. J., 271: 803-807, 1990.
8. Morais-Cabral, J. H., Atkins, G. L., Sánchez, L. M., López-Boado, Y. S., López-Otín. C., and Sawyer, L. Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett., 366: 53-56, 1995.
9. Zeng, C., Spielman, A. I., Vowels, B. R., Leyden, J. L., Bielmann, K., and Preti, G. A human axillary odorant is carried by apolipoprotein D. Proc. Natl. Acad. Sci. USA, 93: 6626-6630, 1996.
10. Haagensen, C. D. The relationship of cystic disease to carcinoma of the breast. In: C. D. Haagensen. Diseases of the Breast, pp. 168-172. Philadelphia: Saunders, 1971.
11. Bundred, N. J., West, R. R., O'Dowd, J., Mansel, R. E., and Hughes, L. E. Is there an increased risk of breast cancer in women who have a breast cyst aspirated? Br. J. Surg., 64: 953-955, 1991.
12. Naldoni, C., Costantini, M., Dogliotti, L., Bruzzi, P., Bucchi, L., Torta, M., and Angeli, A. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. Cancer Res., 52: 1791-1795, 1992.
13. Silva, J. S., Cox, C. S., Wells, S. A., Paull, D., Dilley, W. G., McCarty, K. S., Jr., Fetter, B. F., Glaubitz, L. C., and McCarty, K. S., Sr. Biochemical correlates of morphologic differentiation in human breast cancer. Surgery, 92: 443-449, 1982.
14. Mazoujian, G., and Haagensen, D. E. The immunopathology of gross cyst protein in human breast tumor cytosol. Ann. NY Acad. Sci., 586: 188-197, 1990.
15. Sánchez, L. M., Vizoso, F., Díez-Itza, I., and López-Otín, C. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res., 52: 95-100, 1992.
16. Díez-Itza, I., Vizoso, F., Merino, A., Sánchez, L. M., Tolivia, J., Fernández, J., Ruibal, A., and López-Otín, C. Expression and prognostic significance of apolipoprotein D in breast cancer. Am. J. Pathol., 144: 310-320, 1994.
17. Provost, P. R., Marcel, Y. L., Milne, R. W., Weech, P. K., and Rassart, E. Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett., 290: 139-141, 1991.
18. Simard, J., Dauvois, S., Haagensen, D. E., Lévesque, C., Mérand, Y., and Labrie, F. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology, 126: 3223-3231, 1990.
19. Haagensen, D. W., Stewart, P., Dilley, W. G., and Wells, S. A. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture. Breast Cancer Res. Treat., 23: 77-86, 1992.
20. Simard, J., Veilleux, R., de Launoit, Y., Haagensen, D. E., and Labrie, F. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res., 51: 4336-4341, 1991.
21. Sugimoto, K., Simard, J., Haagensen, D. E., and Labrie, F. Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotetn D secretion in LNCaP human prostate cancer cells. J. Steroid Biochem. Mol. Biol., 51: 167-174, 1994.
22. López-Boado, Y. S., Tolivia, J., and López-Otín, C. Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J. Biol. Chem., 269: 26871-26878, 1994.
23. López-Boado, Y. S., Klaus, M., Dawson, M. I., and López-Otín, C. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARα-dependent signaling pathway. J. Biol. Chem., 271: 32105-32111, 1996.
24. Walters, M. R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev., 13: 719-764, 1992.
25. Bouillon, R., Okamura, W. H., and Norman, A. W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16: 200-257, 1995.
26. 3 on primary cultures of human prostatic cells. Cancer Res., 54: 805-810, 1994.
27. 3 analogues and tamoxifen. Cancer Res., 54: 5711-5717, 1994.
28. 3. Cancer Res., 54: 4057-4064, 1994.
29. 3 are differentially modified by 9-cis-retinoic acid. Cancer Res., 56, 623-632, 1996.
30. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesh, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Ins., 82: 1107-1112, 1990.
31. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
32. 3 or antiestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol., 39: 455-460, 1991.
33. Hall, R. E., Aspinall, J. O., Horsfall, D. J., Birrell, S. N., Bentel, J. M., Sutherland, R. L., and Tilley, W. D. Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. Br. J. Cancer, 74: 1175-1180, 1996.
34. Buras, R. R., Schumaker, L. M., Davoodi, F., Brenner, R. V., Shabahang, M., Nauta, R. J., and Evans, S. R. T. Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat., 31: 191-202, 1994.
35. Binderup, L. Immunological properties of vitamin D analogues and metabolites. Biochem. Pharmacol., 43: 1885-1892, 1992.
36. Colston, K. W., Chander, S. K., Mackay, A. G., and Coombes, R. C. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol., 44: 693-702, 1992.
37. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
38. Anzano, M. A., Smith, J. M., Uskokovic, M. R., Peer, C. W., Mullen, L. T., Letterin, J. J., Welsh, M. C., Shrader, M. W., Logsdon, D. L., Driver, C. L., Brown, C. C., Roberts, A. B., and Sporn, M. B. 1α,25-dihydroxy-16-ene-23-yne-26,27-hexafluoro-cholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res., 54: 1653-1656, 1994.
39. Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA, 85: 3294-3298, 1988.
40. 3 receptor in human breast cancer. Cancer Res., 41: 5121-5124, 1981.
41. 3 receptor in breast cancer. Cancer Res., 47: 6793-6799, 1987.